Metropolitan Life Insurance CO Regenxbio Inc. Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

40 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$18.08 - $24.55 $7,485 - $10,163	-414 Reduced 15.34%	2,284 $43,000
Q4 2022 Jun 14, 2023	BUY	$20.4 - $24.73 $8,445 - $10,238	414 Added 18.13%	2,698 $61.2 Million
Q3 2022 Jun 14, 2023	BUY	$22.29 - $35.04 $9,228 - $14,506	414 Added 18.13%	2,698 $71.3 Million
Q2 2022 Jun 20, 2023	BUY	$19.35 - $35.04 $8,010 - $14,506	414 Added 18.13%	2,698 $66,000
Q1 2022 Jun 20, 2023	BUY	$24.62 - $34.31 $10,192 - $14,204	414 Added 18.13%	2,698 $89,000
Q1 2022 Mar 30, 2023	SELL	$24.62 - $34.31 $204,222 - $284,601	-8,295 Reduced 75.46%	2,698 $89,000
Q1 2022 May 12, 2022	SELL	$24.62 - $34.31 $204,222 - $284,601	-8,295 Reduced 75.46%	2,698 $90,000
Q4 2021 Jun 21, 2023	BUY	$30.19 - $40.28 $262,924 - $350,798	8,709 Added 381.3%	10,993 $359,000
Q3 2021 Jun 21, 2023	BUY	$29.09 - $45.68 $253,344 - $397,827	8,709 Added 381.3%	10,993 $460,000
Q2 2021 Jun 21, 2023	BUY	$32.46 - $40.48 $282,694 - $352,540	8,709 Added 381.3%	10,993 $427,000
Q2 2021 Mar 30, 2023	BUY	$32.46 - $40.48 $17,041 - $21,252	525 Added 5.02%	10,993 $427,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $356,508 - $444,591	10,983 Added 109830.0%	10,993 $427,000
Q1 2021 Jun 26, 2023	BUY	$33.61 - $49.95 $275,064 - $408,790	8,184 Added 358.32%	10,468 $357 Million
Q1 2021 Mar 30, 2023	SELL	$33.61 - $49.95 $2,419 - $3,596	-72 Reduced 0.68%	10,468 $357,000
Q1 2021 May 14, 2021	SELL	$33.61 - $49.95 $353,913 - $525,973	-10,530 Reduced 99.91%	10 $357,000
Q4 2020 Jun 22, 2023	BUY	$26.52 - $49.35 $218,949 - $407,433	8,256 Added 361.47%	10,540 $478,000
Q3 2020 Jun 26, 2023	BUY	$27.01 - $40.26 $222,994 - $332,386	8,256 Added 361.47%	10,540 $290,000
Q2 2020 Jun 26, 2023	BUY	$27.75 - $43.44 $229,104 - $358,640	8,256 Added 361.47%	10,540 $388,000
Q2 2020 Mar 30, 2023	SELL	$27.75 - $43.44 $8,380 - $13,118	-302 Reduced 2.79%	10,540 $388,000
Q2 2020 Aug 14, 2020	SELL	$27.75 - $43.44 $8,380 - $13,118	-302 Reduced 2.79%	10,540 $388,000
Q1 2020 Jul 12, 2023	BUY	$21.5 - $54.2 $183,997 - $463,843	8,558 Added 374.69%	10,842 $351,000
Q4 2019 Jul 12, 2023	BUY	$34.54 - $44.87 $295,593 - $383,997	8,558 Added 374.69%	10,842 $444,000
Q4 2019 Mar 30, 2023	SELL	$34.54 - $44.87 $15,784 - $20,505	-457 Reduced 4.04%	10,842 $444,000
Q4 2019 Feb 14, 2020	SELL	$34.54 - $44.87 $15,784 - $20,505	-457 Reduced 4.04%	10,842 $444,000
Q3 2019 Jul 12, 2023	BUY	$31.84 - $50.88 $287,037 - $458,683	9,015 Added 394.7%	11,299 $402,000
Q3 2019 Mar 30, 2023	BUY	$31.84 - $50.88 $33,113 - $52,915	1,040 Added 10.14%	11,299 $402,000
Q3 2019 Nov 14, 2019	BUY	$31.84 - $50.88 $33,113 - $52,915	1,040 Added 10.14%	11,299 $402,000
Q2 2019 Jul 12, 2023	BUY	$42.0 - $59.29 $334,950 - $472,837	7,975 Added 349.17%	10,259 $527,000
Q1 2019 Jul 13, 2023	BUY	$40.82 - $62.45 $325,539 - $498,038	7,975 Added 349.17%	10,259 $587,000
Q1 2019 Mar 30, 2023	BUY	$40.82 - $62.45 $308,640 - $472,184	7,561 Added 280.24%	10,259 $587,000
Q1 2019 May 16, 2019	SELL	$40.82 - $62.45 $175,117 - $267,910	-4,290 Reduced 29.49%	10,259 $587,000
Q1 2019 May 15, 2019	BUY	$40.82 - $62.45 $175,117 - $267,910	4,290 Added 41.82%	14,549 $363,000
Q4 2018 Jul 13, 2023	BUY	$39.11 - $75.15 $311,902 - $599,321	7,975 Added 349.17%	10,259 $430,000
Q4 2018 Feb 14, 2019	BUY	$39.11 - $75.15 $311,784 - $599,095	7,972 Added 348.58%	10,259 $430,000
Q3 2018 Jul 13, 2023	BUY	$65.0 - $82.15 $518,375 - $655,146	7,975 Added 349.17%	10,259 $775 Million
Q3 2018 Nov 14, 2018	SELL	$65.0 - $82.15 $454,155 - $573,982	-6,987 Reduced 75.34%	2,287 $173,000
Q1 2018 May 15, 2018	BUY	$24.05 - $37.5 $13,011 - $20,287	541 Added 6.19%	9,274 $0
Q4 2017 Feb 15, 2018	SELL	$26.0 - $34.6 $253,942 - $337,938	-9,767 Reduced 52.79%	8,733 $290,000
Q3 2017 Nov 14, 2017	BUY	$18.0 - $32.95 $34,290 - $62,769	1,905 Added 11.48%	18,500 $610,000
Q2 2017 Aug 14, 2017	BUY	N/A	16,595	16,595 $328,000

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

43.5M

Call Options Held

58.9K

Put Options Held

58.4K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $404M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account